Research Use Only — for qualified researchers 99.4% HPLC verified purity Third-party COA per batch Cold-chain dispatched from Switzerland Research Use Only — for qualified researchers 99.4% HPLC verified purity Third-party COA per batch Cold-chain dispatched from Switzerland
EN / USD Partners Sign In
Home / Compounds / Metabolic / CJC-1295 (DAC)
CJC-1295 (DAC) — BIOHACKER
FIG. 01 · BH-753 5mg · 99.1% HPLC
CJC-1295 (DAC)
Metabolic Lyophilised vial
BH-753 · CJC-1295 (DAC)

A 7-day signal. In one dose.

Long-acting GHRH · Drug Affinity Complex

Mass / vial5mg
Purity (HPLC)99.1%
Plasma t½6-8 d
T-max24 hr
Bioavailability75% F
RouteSubQ
$50.00 · per vial
1
View COA
Manufactured in Switzerland. Zürich reference lab. ISO 9001:2015. Lyophilised under nitrogen.
Third-party HPLC-MS COA. A signed certificate is available for any batch on request.
2–8 °C cold chain. Insulated dispatch with temperature logger.
N° 01 — Overview

CJC-1295 (DAC)
at the molecular level.

A 7-day signal. In one dose.

99.1%
HPLC-verified purity, batch-by-batch
5mg
Mass per lyophilised vial
6-8 d
Plasma half-life · SubQ
N° 02 — Mechanism

How it
actually works.

CJC-1295 is a synthetic analogue of growth hormone-releasing hormone (GHRH), modified with a Drug Affinity Complex (DAC) — a lysine-maleimide conjugate that allows the peptide to covalently bind to serum albumin after injection. This albumin binding dramatically extends the circulating half-life from under 30 minutes (for unmodified GHRH analogues) to 6–8 days, enabling once or twice-weekly dosing while maintaining sustained pituitary GH stimulation.

N° 03 — Pharmacokinetics

Vial to
receptor.

Subcutaneous lyophilised formulation. Pharmacokinetic parameters validated by HPLC-MS at our Lausanne reference lab.

T-max24 hrpeak plasma
t½6-8 dplasma half-life
F75% Fbioavailability
RouteSubQadministration
View bioavailability diagram →
N° 04 — Certificate of Analysis

The number
that matters.

Every BIOHACKER batch ships with a third-party HPLC-MS certificate signed by the Lausanne reference lab.

BatchBH-V753-2026-A
HPLC Purity99.1%
Related Impurities< 0.9%
Water (Karl Fischer)< 0.8%
Residual SolventsWithin ICH Q3C
Microbial Load< 10 CFU/g
Endotoxin< 0.1 EU/mg
Issued02.06.2026 · Lausanne
Download full COA (PDF) →
N° 05 — Verified Reviews

From the
field.

No reviews yet. Be the first to document your research results.

From the same
protocol.

All compounds →
Tirzepatide
BH-770 · Tirzepatide
Dual Agonist · GLP-1 / GIP
$480.00
Tesamorelin
BH-768 · Tesamorelin
GHRH Analog · Long-acting Secretagogue
$75.00
AOD-9604
BH-751 · AOD-9604
Growth Hormone Fragment 176-191
$200.00
RESEARCH USE ONLY. All products listed are research peptide compounds intended exclusively for in-vitro laboratory and research purposes. Not for human or animal consumption. Not for therapeutic or diagnostic use. These statements have not been evaluated by the FDA. By proceeding, you confirm you are a qualified researcher operating in a regulated facility. Restricted in: AU, BR, CN, KR, MY. Full compliance disclosure available in our Terms of Sale.